April 22, 2025 06:38 AM EDTUpdated 07:35 AM
Pharma
Manufacturing

Roche promis­es $50B in­vest­ment in the US as phar­ma tar­iffs inch clos­er

Anna Brown

News Reporter

Roche is the lat­est phar­ma gi­ant with new plans to boost its R&D and man­u­fac­tur­ing pres­ence in the US, an­nounc­ing on Tues­day it has bud­get­ed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

As the XBI suf­fers, Q1 shows a few com­fort­ing signs of un­der­ly­ing sta­bil­i­ty

Makary, in one of first com­ments on FDA pol­i­cy, floats new path­way for rare dis­ease drugs

As­traZeneca, Dai­ichi eye first-line breast can­cer mar­ket af­ter En­her­tu's ear­ly Phase 3 win

Chi­na start­up in­jects CRISPR ther­a­py in­to the brain for the first time

FDA plans to ban phar­ma em­ploy­ees from serv­ing on ad­comms. The im­pact will be lim­it­ed

sponsored

AD­STI­LADRIN® (nad­o­fara­gene fi­rade­n­ovec-vncg) – A Grow­ing Body of Clin­i­cal Da­ta and Re­al-World Ev­i­dence

A service from the Financial Times